Novartis
NVS
$97.44
Share price
-1.64%
Change (1 day)
-4.97%
Change (1 year)
Categories
Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.
Novartis (NVS) - Net assets
Net assets on the balance sheet as of December 2023 : $46.75 B
According to Novartis's latest financial reports the company has $46.75 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Novartis - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $46.75 B | -21.33% |
| 2022-12-31 | $59.42 B | -12.38% |
| 2021-12-31 | $67.82 B | 19.69% |
| 2020-12-31 | $56.66 B | 2.01% |
| 2019-12-31 | $55.55 B | -29.41% |
| 2018-12-31 | $78.69 B | 6.02% |
| 2017-12-31 | $74.22 B | -0.89% |
| 2016-12-31 | $74.89 B | -2.89% |
| 2015-12-31 | $77.12 B | 8.86% |
| 2014-12-31 | $70.84 B | -4.87% |
| 2013-12-31 | $74.47 B | 7.52% |
| 2012-12-31 | $69.26 B | 5.04% |
| 2011-12-31 | $65.94 B | -5.49% |
| 2010-12-31 | $69.76 B | 21.42% |
| 2009-12-31 | $57.46 B | 13.93% |
| 2008-12-31 | $50.43 B | 2.11% |
| 2007-12-31 | $49.39 B | 19.62% |
| 2006-12-31 | $41.29 B | 24.51% |
| 2005-12-31 | $33.16 B | 5.9% |
| 2004-12-31 | $31.31 B | 2.61% |
| 2003-12-31 | $30.51 B | 7.71% |
| 2002-12-31 | $28.33 B | 10.87% |
| 2001-12-31 | $25.55 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $68.77 B | 47.11% | 🇺🇸 USA |
 Pfizer PFE | $89.28 B | 90.99% | 🇺🇸 USA |
 Abbott Laboratories ABT | $38.82 B | -16.95% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 75.84% | 🇫🇷 France |
 Merck MRK | $37.63 B | -19.50% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $29.48 B | -36.93% | 🇺🇸 USA |
 AstraZeneca AZN | $39.16 B | -16.22% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $16.28 B | -65.16% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $8.12 B | -82.62% | 🇮🇱 Israel |